T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules

by: aidanmcn
April 9, 2009
4946 views
URL
Embed
Share

Please describe the reason for abuse:



Article:
Peer-Reviewed Paper, View Original
Description:
Theoretical methods for predicting CD8+ T-cell epitopes are an important tool in vaccine design and for enhancing our understanding of the... » More
Citation:
PLoS Comput Biol. 2009 Mar 20; 5(3):e1000327
Authors:
Aidan MacNamara, Ulrich Kadolsky, Charles R. M. Bangham, Becca Asquith

Belongs to:

Loading comments
  1. Yewdell JW, Bennink JR (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.. Annu Rev Immunol 17: 51-88.
  2. Assarsson E, Sidney J, Oseroff C, Pasquetto V, Bui HH (2007) A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.. J Immunol 178: 7890-7901.
  3. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S (2005) An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.. Eur J Immunol 35: 2295-2303.
  4. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.. Science 283: 1748-1752.
  5. Bangham CRM, Osame M (2005) Cellular immune response to HTLV-1.. Oncogene 24: 6035-6046.
  6. Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines.. BMC Bioinformatics 7: 153.
  7. Sette A, Fleri W, Peters B, Sathiamurthy M, Bui HH (2005) A roadmap for the immunomics of category A-C pathogens.. Immunity 22: 155-161.
  8. Sette A, Peters B (2007) Immune epitope mapping in the post-genomic era: lessons for vaccine development.. Curr Opin Immunol 19: 106-110.
  9. Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA (2004) Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.. J Virol 78: 7052-7060.
  10. Drexler I, Staib C, Kastenmuller W, Stevanović S, Schmidt B (2003) Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.. Proc Natl Acad Sci U S A 100: 217-222.
  11. Oseroff C, Kos F, Bui HH, Peters B, Pasquetto V (2005) HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.. Proc Natl Acad Sci U S A 102: 13980-13985.
  12. Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F (2005) HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.. J Immunol 175: 5504-5515.
  13. Wang M, Johansen B, Nissen MH, Thorn M, Kløverpris H (2007) Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors.. Cancer Lett 251: 86-95.
  14. Thorn M, Wang M, Kløverpris H, Schmidt EGW, Fomsgaard A (2007) Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope.. Cancer Immunol Immunother 56: 1755-1763.
  15. Wang M, Lamberth K, Harndahl M, Røder G, Stryhn A (2007) CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.. Vaccine 25: 2823-2831.
  16. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.. Nat Biotechnol 24: 817-819.
  17. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M (2007) Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1.. PLoS Pathog 3: e94doi:10.1371/journal.ppat.0030094.
  18. Borghans JAM, Mølgaard A, de Boer RJ, Keşmir C (2007) HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24.. PLoS ONE 2: e920doi:10.1371/journal.pone.1000920.
  19. Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H (2008) Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads.. PLoS ONE 3: e1424doi:10.1371/journal.pone.1001424.
  20. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S (1999) SYFPEITHI: database for MHC ligands and peptide motifs.. Immunogenetics 50: 213-219.
  21. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K (2004) Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.. Bioinformatics 20: 1388-1397.
  22. Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.. Immunogenetics 57: 304-314.
  23. Peters B, Sette A (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.. BMC Bioinformatics 6: 132.
  24. Heckerman D, Kadie C, Listgarten J (2007) Leveraging information across HLA alleles/supertypes improves epitope prediction.. J Comput Biol 14: 736-746.
  25. Buus S, Lauemøller SL, Worning P, Kesmir C, Frimurer T (2003) Sensitive quantitative predictions of peptide-MHC binding by a ‘Query by Committee’ artificial neural network approach.. Tissue Antigens 62: 378-384.
  26. Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.. Protein Sci 12: 1007-1017.
  27. Peters B, Bui HH, Sidney J, Weng Z, Loffredo JT (2005) A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules.. Vaccine 23: 5212-5224.
  28. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.. Nat Biotechnol 17: 555-561.
  29. George AJT, Stark J, Chan C (2005) Understanding specificity and sensitivity of T-cell recognition.. Trends Immunol 26: 653-659.
  30. Elliott T (2006) The ‘chop-and-change’ of MHC class I assembly.. Nat Immunol 7: 7-9.
  31. Williams AP, Peh CA, Purcell AW, McCluskey J, Elliott T (2002) Optimization of the MHC class I peptide cargo is dependent on tapasin.. Immunity 16: 509-520.
  32. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.. Immunogenetics 50: 201-212.
  33. Korber BTM, Brander C, Haynes BF, Koup R, Moore JP (2005) . HIV Molecular Immunology 2005Los Alamos National Laboratory, Theoretical Biology and Biophysics. Los Alamos, New Mexico.
  34. Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules.. PLoS Comput Biol 2: e65doi:10.1371/journal.pcbi.0020065.
  35. Larsen M, Lundegaard C, Lamberth K, Buus S, Lund O (2007) Large-Scale validation of methods for cytotoxic T-lymphocyte epitope prediction.. BMC Bioinformatics 8: 424.
  36. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules.. Annu Rev Immunol 12: 181-207.
  37. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J (2007) Extensive HLA class I allele promiscuity among viral CTL epitopes.. Eur J Immunol 37: 2419-2433.
No more videos from this user found.
MacNamara et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright 2012 © Aidan MacNamara, Ulrich Kadolsky, Charles R. M. Bangham, Becca Asquith. This pubcast is licensed under the terms of the Creative Commons Attribution License 3.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.